EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In Vitro and In Silico Evaluation of the Anti-Infective Potential of EF24-Analogous Curcuminoids: Antiprotozoal Activity and HIV-1 Ribonuclease H Inhibition

Tariq A Khan iD, Ibrahim S Al Nasr iD, Waleed S Koko iD, Kamal A Qureshi iD, Nhat Quang Tu iD, Clémence Richetta iD, Federica Putzu iD, Laura Dettori iD, Olivier Delelis, Rainer Schobert iD, Angela Corona iD, Bernhard Biersack iD

Pathogens · 20.08.2026 · 15 (8) · 876

DOI: 10.3390/pathogens15080876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 20.08.2026. Verfasst von Tariq A Khan und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia. Hauptthemen laut MEDLINE: Antiprotozoal Agents, HIV-1, Ribonuclease H, Curcumin. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU MUR PNRR, EU funding, RASLR7/07project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin derivatives (curcuminoids) exhibit considerable antiparasitic and antiviral activities. In this study, EF24-like bis-2-fluorobenzylidene piperidone derivatives were synthesized and evaluated for antiprotozoal activity and inhibition of the human immunodeficiency virus (HIV)-1 reverse transcriptase (RT)-associated RNase H (HIV-1 RNase H). A series of bis-arylidene piperidones and tetrahydro(thio)pyranones bearing halogen or nitro substituents were tested against Leishmania major (promastigotes and amastigotes) and Toxoplasma gondii. L. major promastigotes were the most sensitive parasitic model, with several compounds exhibiting low-nanomolar IC50 values, while ortho- or para-halogenated analogues demonstrated submicromolar activity against T. gondii. Among them, 3,4-dichlorophenyl (HPip-DC) and 4-bromophenyl (HPip-4Br) derivatives showed potent activity against L. major and HIV-1 RNase H. The entropy-uncorrected MM-GBSA effective binding energy estimates were −33.41, −9.29, −8.37, and −4.27 kcal/mol for the predicted L. major squalene monooxygenase–HPip-DC, bovine cytochrome bc1–DiFiD (2,4-difluorophenyl derivative), RNase H–HPip-4NO (4-nitrophenyl derivative), and RNase H–HPip-DC complexes, respectively. During 300 ns simulations, the ligands remained associated with their binding pockets. The Arg557 residue was crucial for HPip-4NO-mediated RNase H inhibition while the inhibitory activity of HPip-DC was much less dependent on this amino acid. These findings identify EF24-like curcuminoids with potent in vitro antiprotozoal activity and biochemical inhibition of HIV-1 RNase H. Antiviral activity was observed but confounded by host cell toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsHIV-1Ribonuclease HCurcuminRibonuclease H, Human Immunodeficiency VirusToxoplasmaHumansLeishmaniaAnimalsInhibitory Concentration 50Enzyme Inhibitors

Stichwörter der Autor:innen

EF24 analogsHIVRNase H inhibitorantiparasitic agentscurcuminoidshalogenleishmaniasismolecular dockingtoxoplasmosis

Substanzen

Antiprotozoal AgentsRibonuclease HCurcuminRibonuclease H, Human Immunodeficiency VirusEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Pharmacology and Toxicology, Institute for Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, 6229 ER Maastricht, The Netherlands.
  • Department of Biology, College of Science, Qassim University, Buraydah 51452, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia.
  • Laboratoire de Biologie et Pharmacologie Appliquée (LBPA), ENS-Paris-Saclay, Centre National de la Recherche Scientifique (CNRS) UMR 8113, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.
  • Laboratory of Molecular Virology, Department of Life and Environmental Sciences, University of Cagliari Biomedical Section, E Block, First Floor, Cittadella Universitaria di Monserrato SS554, 09042 Monserrato, CA, Italy.

ORCID-Profile: Tariq A Khan, Ibrahim S Al Nasr, Waleed S Koko, Kamal A Qureshi, Nhat Quang Tu, Clémence Richetta, Federica Putzu, Laura Dettori, Rainer Schobert, Angela Corona, Bernhard Biersack

Förderung

  • EU MUR PNRR
  • EU funding
  • RASLR7/07project

Zitieren

APA

Khan, T. A., Al Nasr, I. S., Koko, W. S., Qureshi, K. A., Tu, N. Q., Richetta, C., Putzu, F., Dettori, L., Delelis, O., Schobert, R., Corona, A., & Biersack, B. (2026). In Vitro and In Silico Evaluation of the Anti-Infective Potential of EF24-Analogous Curcuminoids: Antiprotozoal Activity and HIV-1 Ribonuclease H Inhibition. Pathogens, 15(8), 876. https://doi.org/10.3390/pathogens15080876

Vancouver

Khan TA, Al Nasr IS, Koko WS, Qureshi KA, Tu NQ, Richetta C, et al. In Vitro and In Silico Evaluation of the Anti-Infective Potential of EF24-Analogous Curcuminoids: Antiprotozoal Activity and HIV-1 Ribonuclease H Inhibition. Pathogens. 2026;15(8):876. doi:10.3390/pathogens15080876

BibTeX
@article{Khan2026,
  author = {Khan, Tariq A and Al Nasr, Ibrahim S and Koko, Waleed S and Qureshi, Kamal A and Tu, Nhat Quang and Richetta, Clémence and Putzu, Federica and Dettori, Laura and Delelis, Olivier and Schobert, Rainer and Corona, Angela and Biersack, Bernhard},
  title = {In Vitro and In Silico Evaluation of the Anti-Infective Potential of EF24-Analogous Curcuminoids: Antiprotozoal Activity and HIV-1 Ribonuclease H Inhibition},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {876},
  doi = {10.3390/pathogens15080876}
}
Kostenlos starten →